• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE¿ TRI-EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE¿ TRI-EXTENSION SET; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 385158
Medical Device Problem Code Complete Blockage (1094)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/10/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the bd q-syte¿ tri-extension set was blocked while attempting to deliver medication during use.The following information was provided by the initial reporter: "unable to give medication through lumens of q-syte tri extension.Issue seen while giving medications in ot area to pediatric patient.".
 
Additional Manufacturer Narrative
H.3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes, d10: returned to manufacturer on: 13-jun-2023.H6: investigation summary: it was reported the customer was unable to give medication through the lumens of the q-syte tri-extension set.To aid in the investigation, one unsealed q-syte 15cm small bore tri-extension set was received for evaluation by our quality team.Each extension set was flushed using a luer lock syringe.No occlusion or fluid blockage was detected during the flushing of the device.The syringe was able to connect to the unit properly.A visual inspection did not discover any damage to the tubing or q-syte that could induce the fluid blockage.A device history record review was completed for provided material number 385158, lot 2122453.According to the documented records, the product was manufactured according to the approved manufacturing procedures, specifications, and then released by quality assurance.There were no nonconformance(s), capas or abnormal conditions noted at the time of production.At the time of the dhr review, there were no changes to the process and/or equipment that would have affected the manufacturing of the device.Additional device histories were reviewed for each batch of q-sytes used in the manufacturing of this batch and no related quality issues or process deviations were found.Based on the investigation, the complaint of a leak could not be confirmed.
 
Event or Problem Description
It was reported that the bd q-syte¿ tri-extension set was blocked while attempting to deliver medication during use.The following information was provided by the initial reporter: "unable to give medication through lumens of q-syte tri extension.Issue seen while giving medications in ot area to pediatric patient.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE¿ TRI-EXTENSION SET
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17070905
Report Number9610847-2023-00135
Device Sequence Number6679407
Product Code FPA
UDI-Device Identifier00382903851584
UDI-Public00382903851584
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
NA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,Distributor
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 07/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date04/30/2025
Device Catalogue Number385158
Device Lot Number2122453
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/10/2023
Supplement Date Received by Manufacturer07/05/2023
Initial Report FDA Received Date06/06/2023
Supplement Report FDA Received Date07/24/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/17/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-